Publications

Published studies from members of the consortium.

2025

  1. Indications and Diagnostic Yield of Paraneoplastic and Autoimmune Encephalitis Antibody Testing: A Retrospective Cohort Study. Brain and Behaviour. August 2025;15(8):e70779. Ford H, Seery N, Tan T, Gardner L, Box J, Wesselingh R, Bosco J, Monif M.
  2. The relationship between patient-reported quality of life and clinician-rated outcome scores in patients with autoimmune encephalitis: a study of the Australian Autoimmune Encephalitis Consortium. Quality of Life Research. August 2025. Kazzi C, Seery N, Griffith S, Wesselingh R, Rushen T, Tan TH, Ko KY, Ter Horst L, Skinner G, McLaughlin L, Ford H, Meade C, O'Shea M, Buzzard K, Forcadela M, Duncan A, van der Walt A, D'Souza W, Senvieratne U, Macdonell R, Ramanathan S, Blum S, Reddel SW, Hardy TA, Butzkueven H, O'Brien TJ, Alpitsis R, Malpas CB, Monif M; Australian Autoimmune Encephalitis Consortium.
  3. Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study. Neurol Neuroimmunol Neuroinflamm. May 2025;12(4):e200395. Seery N, Wesselingh R, Beech P, McLaughlin L, Rushen T, Halliday AJ, Ter Horst L, Griffith SP, Forcadela M, Tan TH, Kazzi C, Nesbitt C, Broadley J, Buzzard K, Duncan A, D'Souza WJ, Tran Y, Van Der Walt A, Skinner G, Taylor BV, Swayne A, Brodtmann A, Gillis D, Butler EG, Kalincik T, Seneviratne UK, Macdonell RA, Blum S, Ramanathan S, Malpas CB, Reddel SW, Hardy TA, O'Brien TJ, Sanfilippo PG, Butzkueven H, Monif M; Australian Autoimmune Encephalitis Consortium.
  4. Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody-Mediated Encephalitis: A Multicenter Cohort Study. Neurol Neuroimmunol Neuroinflamm. 2025 Jul;12(4):e200412. doi: 10.1212/NXI.0000000000200412. July 2025. Seery N, Wesselingh R, Beech P, McLaughlin LM, Rushen T, Halliday AJ, Horst LT, Griffith SP, Forcadela M, Tan TH, Kazzi C, Nesbitt C, Broadley J, Buzzard K, Duncan AJ, D'Souza WJ, Tran YD, Van Der Walt A, Skinner G, Taylor BV, Swayne A, Brodtmann A, Gillis D, Butler EG, Kalincik T, Seneviratne UK, Macdonell RA, Blum S, Ramanathan S, Malpas CB, Reddel SW, Hardy TA, O'Brien TJ, Sanfilippo PG, Butzkueven H, Monif M; Australian Autoimmune Encephalitis Consortium.
  5. Multimodal prognostication of autoimmune encephalitis: an Australian autoimmune encephalitis consortium study. J Neurol. April 2025; 272 (5): 361. Seery N, Wesselingh R, Beech P, Broadley J, Griffith S, Rushen T, Beharry J, Tan C, Chiniforoush N, McLaughlin L, Ter Horst L, Forcadela M, Tan T, Kazzi C, Nesbitt C, Buzzard K, Duncan A, Halliday A, D'Souza W, Tran Y, Van Der Walt A, Skinner G, Swayne A, Malpas CB, Brodtmann A, Gillis D, Taylor B, Butler EG, Kalincik T, Seneviratne U, Macdonell R, Blum S, Ramanathan S, Reddel SW, Hardy TA, O'Brien TJ, Sanfilippo P, Butzkueven H, Monif M; Australian Autoimmune Encephalitis Consortium.

2024

  1. Memory function in autoimmune encephalitis: a cross-sectional prospective study utilising multiple memory paradigms. Journal of Neurology. August 2024; 271(8):5610-5621. Griffith SP, Wesselingh R, Seery N, Rushen T, Kyndt C, Long B, Seneviratne U, Kalincik T, Buzzard K, Butzkueven H, O'Brien TJ, Alpitsis R, Malpas CB, Monif M; Australian Autoimmune Encephalitis Consortium
  2. Language impairments in seropositive and seronegative autoimmune encephalitis. Neurological Sciences. July 2024; 45(7):3389-3398. Griffith SP, Wesselingh R, D'Aprano F, Seery N, Rushen T, Kyndt C, Long B, Seneviratne U, Kalincik T, Buzzard K, Butzkueven H, O'Brien TJ, Alpitsis R, Malpas CB, Monif M; Australian Autoimmune Encephalitis Consortium.
  3. Characterising cognitive function in patients with autoimmune encephalitis: an Australian prospective study. Journal of Neurology. January 2024; 271(1):310-324. Griffith SP, Wesselingh R, Seery N, Rushen T, Kyndt C, Long B, Seneviratne U, Buzzard K, Butzkueven H, O'Brien TJ, Alpitsis R, Malpas CB, Monif M; Australian Autoimmune Encephalitis Consortium.

2023

  1. Movement disorders in cell surface antibody mediated autoimmune encephalitis: a meta-analysis. Frontiers in Neurology. July 2023; 14:1225523. Siriratnam P, McArthur L, Chen Z, Kempster P, Monif M.
  2. Peripheral monocytes and soluble biomarkers in autoimmune encephalitis. Journal of Autoimmunity, 2023; 135 R Wesselingh, S Griffi th, J Broadley, D Tarlinton, K Buzzard, U Seneviratne, H Butzkueven, TJ O’Brien, M Monif
  3. Neuroimaging characteristics may aid in diagnosis, subtyping, and prognosis in autoimmune encephalitis. Neurol Sci. April 2023; 44(4):1327-1340. Broadley J, Wesselingh R, Beech P, Seneviratne U, Kyndt C, Buzzard K, Nesbitt C, D'Souza W, Brodtmann A, Macdonell R, Kalincik T, O'Brien TJ, Butzkueven H, Monif M; Australian Autoimmune Encephalitis Consortium.

2022

  1. Prevalence, risk factors, and prognosis of drug resistant epilepsy in autoimmune encephalitis. Epilepsy & Behavior: E&B, 132, 108729. July 2022. Wesselingh, R., Broadley, J., Buzzard, K., Tarlinton, D., Seneviratne, U., Kyndt, C., Stankovich, J., Sanfilippo, P., Nesbitt, C., D’Souza, W., Macdonell, R., Butzkueven, H., O’Brien, T. J., Monif, M.
  2. Rare antibody-mediated and seronegative autoimmune encephalitis: An update. Autoimmunity Reviews. July 2022; 21(7):103118. Seery N, Butzkueven H, O'Brien TJ, Monif M.
  3. Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides. Autoimmunity Reviews. May 2022; 21(5):103074. Seery N, Butzkueven H, O’Brien TJ, Monif M.
  4. Psychometric deficits in autoimmune encephalitis: A retrospective study from the Australian Autoimmune Encephalitis Consortium. European journal of neurology, April 2022. Griffith, S., Wesselingh, R., Broadley, J., O’Shea, M., Kyndt, C., Meade, C., Long, B., Seneviratne, U., Reidy, N., Bourke, R., Buzzard, K., D’Souza, W., Macdonell, R., Brodtmann, A., Butzkueven, H., O’Brien, T. J., Alpitsis, R., Malpas, C. B., Monif, M., & Australian Autoimmune Encephalitis Consortium.
  5. Autoimmune Encephalitis in Long-Standing Schizophrenia: A Case Report. Frontiers in Neurology. February 2022; 12:810926. Vaux A, Robinson K, Saglam B, Cheuk N, Kilpatrick T, Evans A, Monif M.
  6. Electroclinical biomarkers of autoimmune encephalitis. Epilepsy & Behavior: E&B, March 2022. Wesselingh, R., Broadley, J., Buzzard, K., Tarlinton, D., Seneviratne, U., Kyndt, C., Stankovich, J., Sanfilippo, P., Nesbitt, C., D'Souza, W., Macdonell, R., Butzkueven, H., O'Brien, T. J., & Monif, M.

2021

  1. Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis. Journal of neuroimmunology. Journal of Neuroimmunology, April 2021. Broadley, J., Wesselingh, R., Seneviratne, U., Kyndt, C., Beech, P., Buzzard, K., Nesbitt, C., D'souza, W., Brodtmann, A., Macdonell, R., Kalincik, T., Butzkueven, H., O'Brien, T. J., Monif, M., & Australian Autoimmune Encephalitis Consortium
  2. Peripheral Immune Cell Ratios and Clinical Outcomes in Seropositive Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium. Frontiers in immunology, January 2021, Broadley, J., Wesselingh, R., Seneviratne, U., Kyndt, C., Beech, P., Buzzard, K., Nesbitt, C., D'Souza, W., Brodtmann, A., Kalincik, T., Butzkueven, H., O'Brien, T. J., Monif, M., & Australian Autoimmune Encephalitis Consortium

2020

  1. The neuropsychological spectrum of anti-LGI1 antibody-mediated autoimmune encephalitis. Journal of Neuroimmunology. August 2020; 345:577271. Griffith SP, Malpas CB, Alpitsis R, O'Brien TJ, Monif M.
  2. Seizures in autoimmune encephalitis: Kindling the fire. Epilepsia. June 2020; 61(6):1033-1044. Wesselingh R, Butzkueven H, Buzzard K, Tarlinton D, O'Brien TJ, Monif M.

2019

  1. Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle? Frontiers in immunology. September 2019. Wesselingh, R., Butzkueven, H., Buzzard, K., Tarlinton, D., O'Brien, T. J., & Monif, M.

2018

  1. Prognosticating autoimmune encephalitis: A systematic review. Journal of Autoimmunity. January 2019; 96:24-34.  Broadley J, Seneviratne U, Beech P, Buzzard K, Butzkueven H, O'Brien T, Monif M.